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1. Introduction  
A current challenge in the field of tissue engineering is soft tissue replacement. Techniques 
for soft tissue reconstruction include use of autologous fat transplantation, alloplastic 
implants and autologous tissue flaps. However, these approaches have disadvantages, 
including donor-site morbidity, implant migration, foreign body reaction and immune 
system rejection. The use of autologous stem cells expanded in vitro and combined with 
novel biomaterials for organ reconstruction offers a potential solution for replacement of 
tissue or whole organs. Stem cells, first identified in embryonic tissue and later in numerous 
adult tissues, possess the unique capacity to differentiate into wide range of tissue types. 
However, although embryonic cells are the most flexible of stem cell lines, they raise the 
problem of ethical issues. For tissue engineering, candidates of stem cells include embryonic 
stem cells (Ahn, et al.), induced pluripotent stem cells (iPS) (Crisan, et al.;2008, Parker, et 
al.;2007) and adult stem cells. The ability of adult stem cells to divide or self-renewal make 
them attractive source of stem cells for use in tissue engineering. A significant amount of 
current interest has focused on the possibility that adult human stem cells are the 
therapeutic alternative to embryonic stem cells because of their plasticity (Aoki, et al.;2010). 
The presence of self-renewing cells within the bone marrow of mice was reported in 1963 
which was later known as hematopoietic stem cells (HSCs) (Becker, et al.;1963, Zhang, et 
al.;1999). Several years later, HSCs were identified in umbilical cord blood by other 
investigators (Aust, et al.; 2004, Dellavalle, et al.;2007). Furthermore, several other adult stem 
cell types such as neural stem cells (Dellavalle, et al.; 2007, Guilak, et al.;2010), were isolated 
and identified. Moreover, a population of plastic adherent cells were isolated from 
collagenase digests of adipose tissue.  
Adipose tissue derived stem cells were termed as: adipose derived stem/stromal cells 
(ASCs), adipose-derived adult stem (ADAS) cells, adipose-derived adult stromal cells, 
adipose-derived stromal cells (ADSCs), adipose stromal cells (ASCs), adipose mesenchymal 
stem cells (AdMSCs), lipoblast, pericyte, preadipocyte, and processed lipoaspirate (PLA) 
cells. To prevent the confusion in the literature, the International Fat Applied Technology 
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Society reached a consensus to adopt the term “adipose-derived stem cells” (ASCs) to 
identify the isolated, plastic-adherent, multipotent cell population (Gimble, et al.;2007). 
Adipose tissue derives from the mesodermal layer of the embryo and develops both pre- 
and postnatally (Gonda, et al.;2008, Kakudo, et al.;2008). Researchers studying the 
development of adipose tissue have long worked with a fibroblastic cell line, known as 
preadipocytes, isolated from adipose tissue (Cowherd, et al.;1999, Gregoire, et al.;1998, 
Kirkland and Hollenberg;1998, Nam and Lobie;2000, Sorisky;1999).   
The reason why adipose tissue would contain a stem cell population is not still clear. There 
is some discussion whether the cells are subpopulation of fibroblasts reside within the fat 
tissue or are perhaps mesenchymal or peripheral blood stem cells passing through the fat 
tissue (Crisan, et al.; 2008, Dellavalle, et al.; 2007).  
The ASCs represent a readily available source for isolation of potentially useful stem cells 
(Sterodimas, et al.; 2010). In culture, they have shown to have an impressive developmental 
plasticity, including the ability to undergo multilineage differentiation and self-renewal 
(Liu, et al.; 2009). When ASCs are compared with BM-MSCs, further similarities have been 
demonstrated in regards to their growth kinetics, cell senescence, gene transduction 
efficiency (De Ugarte, et al.; 2003), as well as CD surface marker expression (Gronthos, et al.; 
2001, Katz, et al.; 2005, Zuk, et al.; 2002) and gene transcription (Katz, et al.; 2005). Compared 
to bone marrow MSCs, ASCs have potential advantages for tissue engineering application, 
because of the tissue accessibility, multipotency and ease of isolation without painful 
procedures or donor site injury. 
In this chapter we will discuss the potential use of adipose-derived stem cells in the field of 
tissue engineering.   
2. Isolation and expansion of ASCs 
The initial methods to isolate cells from adipose tissue were pioneered by Rodbell and 
colleagues in the 1960s (Rodbell; 1966, Rodbell; 1966, Rodbell and Jones; 1966) using rat fat 
tissue. These methods were further adapted for human tissues by several other groups 
(Deslex, et al.; 1987, Engfeldt, et al.; 1980, Ho, et al.; 2010). The current methods for isolating 
ASCs rely on a collagenase digestion followed by centrifugal separation to isolate the 
stromal/vascular cells from primary adipocytes. The pellet is resuspended with a basal 
medium containing 10% foetal bovine serum (Estes, et al.; 2008). The cell suspension is 
filtered through 100 µm cell strainer and the cells are plated and incubated at 37°C in the 
presence of 5% CO2. The medium is changed every second day until the cells reach 80-90% 
confluence. A large number of ASCs can be harvested in this manner, with yields of 
approximately 250,000 cells per gram of tissue (Aust, et al.; 2004, Guilak, et al.; 2010). In 
order to remove the use of animal products in human ASC cultures, a very low human 
serum expansion medium and a completely serum-free medium have been recently 
reported (Parker, et al.; 2007). Furthermore it was reported that use of platelet- rich plasma 
can enhance the proliferation of human ASCs. These results can support the clinical 
application of platelet-rich plasma for cell based, soft-tissue engineering and wound healing 
(Kakudo, et al.; 2008).  
ASCs should be harvested at 80% confluence for freezing. Cryopreservation medium 
consists of 80% fetal bovine serum, 10% dimethylsulfoxide (DMSO) and 10% DMEM/Ham’s 
F-12. The cells should be stored in a final concentration of 1–2 million viable cells per 
milliliter of cryopreservation medium. Aliqouted vials are first frozen in an alcohol freezing 
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container and store and are stored at -80°C overnight. On the next day, the frozen vials can 
be transferred to a liquid nitrogen container for long-term storage. Successful storage of 
ASCs more than 6 months has been shown. This ensures the availability of autologous 
banked ASCs for clinical applications in the future (De Rosa, et al.;2009, Gonda, et al.;2008).  
2.1 Characterization of ASCs 
In order to characterize the undifferentiated animal or human ASC cells cultured in vitro 
flow cytometric and immunohistochemical methods are widely used (Gronthos, et al.; 2001, 
Zuk, et al.; 2001). The cell surface phenotype of ASC is quite similar to MSCs (mesenchymal 
stem cells). Both ASC and MSC cells express CD29, CD44, CD71, CD90, and CD105 (Zuk, et 
al.; 2002). In contrast, no expression of the hematopoietic lineage markers CD31, CD34 and 
CD45 was observed in either of the cultures. In addition the ASC cells express the neutral 
endopeptidase (CD10 or common acute lymphocytic leukemia antigen CALLA), 
aminopeptidase (CD13), and ecto nucleotidase (CD73). Furthermore, ASC cells produce 
Type I and Type III collagens, osteopontin, ostenectin, Thy-1 (CD90), and MUC-18 (CD146) 
(Gimble and Guilak; 2003).  
Different investigator have reported different pattern of expression. For example, while 
Gronthos et al. (Gronthos, et al.;2001) detected CD34 and VCAM (CD106) on ASC cells, Zuk 
et al. (Zuk, et al.;2002) did not. Likewise, while Zuk et al. (Zuk, et al.;2002) detected Stro-1, 
Gronthos et al. did not. These discrepancies could be due to the differences in cell isolation 
methods, how long the cells were cultured prior to analysis and sensitivity differences 
between immunohistochemical and flow cytometric detection methods (Zuk, et al.;2002, 
Zuk, et al.;2001). 
3. ASCs applications  
Adipose tissue has proven to serve as an abundant source of adult stem cells with 
multipotent properties suitable for tissue engineering and regenerative medical 
applications. ASCs can be differentiated into variety of cell types. Differentiation is 
commonly induced by insulin, dexamethasone, cyclic AMP agonist, ǃ-glycerophosphate, 
heparin, ascorbate and different cytokines depending on the lineage type.  
ASCs like BM-MSCs, differentiate in vitro towards soft tissue such adipocytes, smooth 
muscle and cardiac myocytes when treated with established lineage-specific factors. In 
addition they can differentiate toward musculoskeletal tissues such as osteocytes, myocytes 
and chondrocytes. Furthermore neurogenic differentiation of these cells is reported by 
several investigators.  
3.1 ASCs differentiation 
3.1.1 Adipogenesis 
ASCs in response to inductive compounds including glucocorticoid receptor ligands 
(dexamethasone), insulin, cyclic AMP agonist (forskolin) and peroxisome proliferator-
activated receptor gamma (PPARǄ) undergo adipogenic differentiation (Farmer; 2006, 
Hauner, et al.; 1989, Lazar; 2005, Zuk, et al.; 2001). During the differentiation process ASCs 
reduce their proliferation rate and undergo morphological changes. ASCs are induced in the 
adipocyte differentiation medium containing biotin, d-pantothenate, dexamethasone, 
methylisobutylxanthine, insulin and equivalent PPARγ agonist. After induction for 2 weeks 
in adipogenic medium the human ASC contain vacuoles filled with neutral lipid cells which 
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can be further stained for intracellular lipid droplets accumulation using an Oil Red O stain 
(Preece;1972).  
In addition, these cells secrete increased amounts of the adipocyte protein leptin, and 
transcribe adipogenic mRNAs such as the fatty acid binding protein, aP2 and lipoprotein 
lipase (Halvorsen, et al.; 2001, Hauner, et al.; 1989, Sen, et al.; 2001). Some of these 
parameters such as leptin, aP2 mRNA levels were quantified and found to be increased by 
several hundred-fold during the differentiation process (Halvorsen, et al.; 2001, Sen, et al.; 
2001). It is reported that ASCs harvested from female mice differentiate more efficiently into 
adipocytes than those from male mice (Ogawa, et al.; 2004).  
One of the most important uses of ASCs is for the replacement of adipose tissue itself. Large 
soft tissue defects are a common problem following trauma, burns and oncological 
resections. Several studies demonstrated the in vitro differentiation of ASCs along 
adipogenic lineages, including the accumulation of intracellular lipid droplets, and the 
expression of characteristic proteins and enzymes (Ogawa, et al.; 2004, Tchkonia, et al.; 2002, 
Zuk, et al.; 2002). ASCs were used to seed artificial scaffolds and were further implanted 
subcutaneously in mice and rats (von Heimburg, et al.; 2001, von Heimburg, et al.; 2001). 
The cell-seeded grafts showed significant neovascularisation of the implant, as well as 
penetration of the preadipocytes or ASCs into the scaffolding, and their differentiation into 
mature lipid-laden adipocytes. 
3.1.2 Smooth muscle  
ASCs can be differentiated to smooth muscle cells (SMCs) and might offer a cell source for 
hollow organ engineering. For myogenic differentiation ASCs at passages 3 through 5 are 
cultured in smooth muscle inductive medium consisting of MCDB131 supplemented with 
1% FBS and 100u/ml of heparin for up to 6 weeks at 37°C with 5% CO2. The media is 
changed every 3 days and cell splitting is not required (Jack, et al.; 2009).  
The cellular changes after differentiation can be investigated by real- time PCR at mRNA 
level. As reported the expression of muscle actin (SMA), calponin and myosin heavy chain 
showed an increase after growth in differentiation medium (Jack, et al.; 2009). The same was 
observed at protein levels, induction media induced differentiation of the ASCs into a 
smooth muscle phenotype in which the expression of smooth muscle specific proteins SMA, 
caldesmon, and myosin heavy chain (MHC) was increased (Jack, et al.; 2009). 
Differentiation is a complex process and has a dramatical effect on cell size, shape, 
membrane potential, metabolic activity and responsiveness to external signals. One of the 
main characteristic of SMCs is their contractility which plays important roles in 
angiogenesis, blood vessel maintenance, and mechanical regulation of hollow organs such 
as bladder.  
Differentiated SMCs can show two specific phenotypes, which vary from synthetic and 
proliferative to contractile and quiescent (Beamish, et al.; 2010). SMCs exhibit a contractile 
phenotype characterized by high expression of specific contractile proteins including SMA, 
calponin, SM22, smoothelin, h-caldesmon and smooth muscle myosin heavy chain (SM-
MHC) (Owens, et al.; 2004, Shanahan, et al.; 1993).  
Since differentiated human ASCs express smooth muscle specific proteins they may prove 
to be of value in the repair of smooth muscle defects in the gastrointestinal and urinary 
tracts. Juan et al. reported that the ASCs from different sites show different myogenic 
differentiation abilities in vitro. ASCs from the adipose tissues of the nape of the neck and 
www.intechopen.com
 
Adipose-Derived Stem Cells (ASCs) for Tissue Engineering 
 
183 
vicinity of epididymis can be used as ideal seed cells for tissue engineering of lower urinary 
tract (Yuan, et al.; 2010). Similar study was performed by other group using human 
subcutaneous and omental adipose tissues. They could show that subcutaneous adipose 
tissue has higher differentiation capacity than omental adipose tissue which can be a 
suitable cell source for use in regenerative medicine (Toyoda, et al.; 2009). 
3.1.3 Osteogenesis. Bone defect repair 
In the past decade, several groups isolated cells from the adipose tissue of humans and 
other species capable of differentiating into osteoblasts in vitro (Dragoo, et al.; 2003, Mizuno, 
et al.; 2002, Zuk, et al.; 2001). ASC cells differentiate into osteoblast-like cells in the presence 
of ascorbate, b-glycerophosphate, dexamethasone and vitamin D3.  
For osteogenic differentiation confluent ASCs cells are incubated for 3 weeks in DMEM 
containing 10% FBS, 100 nM dexamethasone, 10 mM ǃ-glycerophosphate and 50 μM L-
ascorbic acid-2-phosphate. After fixation cells are incubated at 37°C for 1 hour with 0.16% 
naphthol AS-TR phosphate and 0.8% Fast Blue BB dissolved in 0.1 M tris buffer (pH 9.0). For 
osteogenic differentiation cells were also incubated in 1% alizarin red S for 3 minutes to 
detect calcium deposition (Sakuma, et al.; 2009). 
Over a 2- 4 week period in vitro , both human and rat ASC cells deposit calcium phosphate 
mineral within their extracellular matrix, and express osteogenic genes. Under osteogenic 
conditions ASCs are observed to express genes and proteins associated with osteoblasts 
phenotypes such as osteopontin, osteonectin, osteocalcin collagen type I, BMP-2 and BMP-4 
(Halvorsen, et al.; 2001, Zuk, et al.; 2001). In addition ASCs are able to form mineralized 
matrix in vitro in both long term 2-D or 3-D osteogenic cultures. 
In vivo, ASC cells embedded in porous cubes of hydroxyapatite/tricalcium phosphate form 
bone were used as implants in immunodeficient mice (Hicok, et al.; 2004). New osteoid, 
derived from the human ASC cells, is present within a 6-week incubation period (Hicok, et 
al.; 2004). This finding indicates that ASCs cells will have therapeutic applications in bone 
repair. The first case of autologous ASC use for osseous repair has been reported in the 
treatment of a calvarial defect in a7-year-old girl (Lendeckel, et al.; 2004). Using different 
type of scaffolds, human ASC can form bone in immunodefficient mice (Hicok, et al.; 2004, 
Lee, et al.; 2003). 
3.1.4 Myogenesis: skeletal muscle repair 
There is several line of evidence that ASC cells can differentiate along each of the myocyte 
lineage pathways when cultured in myogenic induction medium containing 0.1 mM 
dexamethasone, 50 mM hydrocortisone, 10% FBS and 5% horse serum. ASCs express MyoD 
and myogenin, transcription factors regulating skeletal muscle differentiation (Pittenger, et 
al.; 1999, Zuk, et al.; 2001).  
Skeletal myogenesis is characterized by a period of myoblast proliferation, followed by the 
expression of muscle-specific proteins and fusion to form multinucleated myotubules. Early 
myogenic differentiation is characterized by the expression of several myogenic regulatory 
factors including myogenic determination factor MyoD1 (Weintraub, et al.; 1991). 
Terminally differentiated myoblasts can be characterized by the expression of myosin and 
the presence of multiple nuclei (Silberstein, et al.; 1986).  
In the first in vivo report, F Bacou et al injected ASCs into the anterior tibialis muscle of 
rabbits following cardiotoxin-induced injury. Consistent with prior work using satellite cells 
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treated muscles were found to be heavier, have an increased fibre area cross-section and 
exert greater maximal force (Boubaker el Andalousi, et al.; 2002). 
3.1.5 Chondrogenesis 
ASCs display chondrogenic characteristics following induction with ascorbate, 
dexamethasone and transforming growth factor-β (Awad, et al.; 2003, Huang, et al.; 2004, 
Zuk, et al.; 2001). Under inductive conditions ASCs express aggrecan, chondroitin sulphate, 
collagen type II and IV and proteoglycans associated with chondrogenic phenotype.(Awad, 
et al.; 2004, Erickson, et al.; 2002, Wickham, et al.; 2003, Zuk, et al.; 2001) 
For chondrogenic differentiation, ASCs cells are grown to confluency in 30-mm dishes and 
incubated for 3 weeks in DMEM containing 1% FBS, 50 mM L-ascorbic acid-2-phosphate, 40 
mg/ml proline, 100 mg/ml pyruvate, 10 ng/ml transforming growth factor (Harriman, et 
al.)-b3, and 1x ITS. Induction medium is replaced every 3 days. At the indicated time points, 
differentiated cells are fixed for 1h with 4% paraformaldehyde and rinsed with PBS. 
Accumulation of chondrocyte matrix is detected with alcian blue staining (pH 2.5, Wako) 
(Matsumoto, et al.; 2008). 
3.1.6 Neuronal differentiation 
There is preliminary evidence suggesting that human ASCs can display neuronal and/or 
oligodendrocytic markers. ADSC at passages 2–5 are seeded in six-well plates at 40%–60% 
confluence. After three washes with PBS, the cells are induced with NIM (DMEM 
supplemented with 500 mM IBMX, 200 mM INDO, and 5 mg/ml insulin) for 1 hr. The cells 
are then examined for the expression of neuronal markers S100, NF70, and nestin followed 
by hematoxylin-eosin (HE) staining (Ning, et al.; 2006).  
The in vivo test for the therapeutic potential of ASCs looked at their effects when injected 
intraventricularly in rats. ASCs survived with increased engraftment at the site of injury 
compared with controls. Neural lineage markers microtubule-associated protein-2 and glial 
fibrillary acidic protein were expressed in some engrafted cells. Behavioural tests of the 
motor and sensory systems showed clear improvements in those treated with ASCs after 
infarct (Kang, et al.; 2003). It is not clear whether transplanted cells replaced the lost neurons 
or provided a support role for existing stem cells and injured neurons. Furthermore, in a  co-
culture model, Kang et al. studied the interactions between neural stem cells (NSCs) and 
ASCs. In comparison to laminin-coated dishes, ASC feeder layers showed ability to support 
the differentiation and survival of NSCs over 14 days in culture. 
4. Biomaterials in tissue engineering with ASCs 
Currently, autologous and allogenic adipose tissues represent a ubiquitous source of 
material for fat reconstructive therapies. However, these approaches are limited, and often 
accompanied by a 40–60% reduction in graft volume following transplantation.  A number 
of factors including a stable scaffold support structure and vascularisation is necessary to 
support de novo adipogenesis and long-term maintenance of adipose tissue formation within 
adipose tissue engineered constructs (Patrick, et al.; 2002). Recently, cell-based approaches 
utilizing adipogenic progenitor cells in combination with biomaterial carriers for fat tissue 
engineering have been developed and were reported to promote both short-term in vivo 
adipogenesis and to repair defect sites (Borges, et al.; 2003, Patrick, et al.; 1999). To date, 
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however the efficacy of exogenously delivered stem cell populations to support the 
generation of long-term volume stable adipose tissue in vivo is restricted by suboptimal 
properties of their biomaterial carriers including insufficient biocompatibility and rapid 
scaffold degradation rates (Patrick, et al.; 2002).  
For functional tissue replacement such as bone, Silk-based biomaterials have previously 
been demonstrated to offer exceptional benefits over conventional synthetic (e.g. poly-
glycolic and lactic acid copolymers) and natural (e.g. collagen type I) biomaterials (Meinel, 
et al.; 2004). The slow degradation and mechanical integrity of silk scaffolds in comparison 
with other conventional biomaterials such as collagen and PLA, above all for long-term in 
vivo studies, suggest that silk fibroin-based scaffolds would be an optimal biomaterial for 
long-term adipose tissue growth and function (Mauney, et al.; 2007). Also, previous studies 
have demonstrated the ability of adipocytes to secrete various paracrine factors which can 
positively influence both the migration and differentiation of preadipocytes (Shillabeer, et 
al.; 1989). Mauney et al. studied biomaterials derived from silk fibroin prepared by aqueous 
(AB) and organic (HFIP) solvent-based processes, along with collagen (COL) and poly-lactic 
acid (PLA)-based scaffolds in vitro and in vivo for their utility in adipose tissue engineering 
strategies (Mauney, et al.; 2007). 
For in vitro studies, they used adipose-derived mesenchymal stem cells (hASCs) and seeded 
them on the various biomaterials and cultured them for 21 days in the presence of 
adipogenic stimulants (AD). In their study, hASCs (and hMSCs) cultured on all biomaterials 
in the presence of AD showed significant upregulation of adipogenic mRNA transcript 
levels (e.g. GLUT4) to similar extents when compared to noninduced controls (Mauney, et 
al.; 2007). Also, oil-red O analysis of hASC-seeded scaffold displayed substantial amounts of 
lipid accumulating adipocytes following cultivation with AD. Following a 4-week 
implantation period in a rat muscle pouch defect model, both AB and HFIP scaffolds 
supported in vivo adipogenesis either alone or seeded with hASCs (Mauney, et al.; 2007). On 
the other hand, COL and PLA scaffolds underwent rapid scaffold degradation and were 
irretrievable following the implantation period. The authors concluded that macroporous 
3D AB and HFIP silk fibroin scaffolds offer an important platform for cell-based adipose 
tissue engineering applications, and in particular, provide longer-term structural integrity to 
promote the maintenance of soft tissue in vivo (Mauney, et al.; 2007). 
Tissue-specific scaffolds and signalling systems are essential to differentiate stem cells into 
the required cells and use them effectively to construct three-dimensional (3D) tissues 
(Sterodimas, et al.; 2010). It has also been proved that adipose tissues engineered with ASCs 
and type I collagen scaffolds can serve in vivo for the replacement of damaged tissue (Lu, et 
al.; 2006). This has been confirmed by Zhang et al., where collagen I scaffold exhibited 
excellent cellular compatibility and can be used as a vehicle for adipose tissue engineering 
(Zhang, et al.; 2007).  
Porous collagenous microbeads can be useful as injectable cell delivery vehicles for adipose-
derived stem cells, allowing ex vivo proliferation and differentiation on particles that are 
small enough to be injected into a defect and molded into the desired shape without 
migration of the cells. The cell-seeded microbeads can be injected through a needle into the 
wound site, and agglomeration of the microbeads can retain the cells and microbeads in the 
site (Rubin, et al.; 2007). Furthermore, the use of natural material hold promises in tissues 
engineering.  
Placental decellular matrix (PDM) holds potential as a scaffold for adipose tissue 
engineering applications. The placenta is a rich source of human extracellular matrix (ECM) 
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components that can be harvested without harm to the donor. Constructs derived from the 
ECM may mimic the native environment of the body, promoting normal cellular 
organization and behavior. Natural materials also have advantages in terms of ease of 
processing, biodegradability and biocompatibility (Schmidt and Baier; 2000). Cell-adhesive 
placental decellular matrix scaffolds facilitate proliferation and viability, while 
differentiation is augmented when the cells are encapsulated in non-adhesive cross-linked 
hyaluronan (XLHA) scaffolds (Flynn, et al.; 2008). Incorporation of XLHA into the PDM 
scaffolds may improve the construct bulking properties and may influence cellular 
infiltration, differentiation and wound healing (Shu XZ; 2004). 
Other candidate for suitable scaffolds is non-woven polyglycolic acid (PGA) and hyaluronic 
acid gel. In a recent study it has been shown that more adipose-tissue-like construct is 
regenerated when using type I collagen sponge than when the non-woven polyglycolic acid 
or hyaluronic acid gel are used (Itoi, et al.; 2010). In addition, significant evidence has been 
shown that ASCs and PLGA spheres can be used in a clinical setting to generate adipose 
tissue as a noninvasive soft tissue filler (Choi, et al.; 2006).  
Altman et al. could show that human adipose-derived stem cells seeded on a silk fibroin-
chitosan scaffold enhance wound healing and show differentiation into fibrovascular, 
endothelial, and epithelial components of restored tissue (Altman, et al.; 2009). In addition, 
it has been shown that transfection of human ASCs with liposome- enveloped xenogenic 
protein from a neonatal rat tissue preparation can induce differentiation of stem cells along 
the directed lineage (Gaustad, et al.; 2004). These observations support the hypothesis that 
the inductive biochemical and structural cues of the microenvironment are conserved across 
species and that a silk fibroin-chitosan delivery vehicle can provide a beneficial niche in 
supporting migration, proliferation, and differentiation of the applied cells (Altman, et al.; 
2009). 
Another complex biomolecule which has sparked great interest for tissue engineering is 
Hyaluronic acid which has been stated to support the growth and development of 
progenitor cells (Brun, et al.; 1999, Solchaga, et al.; 1999). The material has a progressive rate 
of biodegradation, lacks cytotoxicity and does not induce a systemic immune response or 
chronic inflammation in a human in vivo model (Stillaert, et al.; 2008).  Hyaluronic acid-
based (HA) scaffolds were demonstrated to be suitable materials for soft-tissue 
regeneration; they maintain volume when seeded with preadipocytes. Hemmrich et al. 
evaluated, in vitro and in vivo, human preadipocytes seeded onto plain hyaluronan benzyl 
ester (HYAFF®11) or HYAFF®11 coated with the extracellular matrix glycosaminoglycan 
hyaluronic acid and they found extensive formation of new vessels throughout the construct 
but with only minor adipose tissue (Hemmrich, et al.; 2005). 
Long-standing, 3D predefined-shape adipose tissue from hAD-MSCs of human adipose 
tissue remains a challenge. Lin et al. cultured scaffolds (Gelatin sponges, monofilament 
polypropylene and polyglycolic acid meshes) with hAD-MSCs in adipogenic medium for 2 
weeks before implantation, and implanted scaffolds were harvested after 2, 4, and 6 months 
in vivo. All of the successfully harvested scaffolds were filled with newly formed adipose 
tissue and had retained their predefined shape and dimensions (Lin, et al.; 2008). It has been 
shown that hAD-MSCs are not successful soft tissue filler if used alone (Lin, et al.; 2008, 
Moseley, et al.; 2006). 
There are numerous adipose tissue engineering culture strategies in which the core tissue 
engineering principles comprising appropriate cells, scaffold, and microenvironment are 
optimized (Patrick; 2001). Specifically, there are static versus dynamic culture, co-
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cultivation, and addition of growth factors, vascularization, and long-term sustainability of 
engineered constructs. The advantage of dynamic culture includes increased nutrient and 
oxygen delivery to cells within a 3D construct (Frye and Patrick; 2006). Improved bioreactor 
designs to address direct perfusion conditions are necessary to advance dynamic culture 
techniques (Choi, et al.; 2010). 
It has been shown that hASCs express pericyte lineage markers in vivo and in vitro, exhibit 
increased migration in response to PDGF-BB in vitro, exhibit perivascular morphology when 
injected in vivo, and contribute to increases in microvascular density during angiogenesis by 
migrating toward vessels (Amos, et al.; 2008). In cell-assisted lipotransfer (CAL), autologous 
ASCs are used in combination with lipoinjection (e.g. Parry-Romberg syndrome). A stromal 
vascular fraction (SVF) containing ASCs is freshly isolated from half of the aspirated fat and 
recombined with the other half. The preliminary results suggest that CAL is effective and 
safe for soft-tissue augmentation and superior to conventional lipoinjection and 
microvasculature can be detected more prominently in CAL fat (Yoshimura, et al.; 2008). 
Recently, adipose stem cells have proved to selectively induce neovascularisation and 
increase the viability of random-pattern skin flaps. This mechanism might be both due to the 
direct differentiation of ASCs into endothelial cells and the indirect effect of angiogenic 
growh factors released from ASCs (Lu, et al.; 2008). 
5. Conclusion 
ASCs provide an abundant and readily accessible source of multipotent stem cells. The use 
of autologous stem cells expanded in vitro and combined with novel selected biomaterials 
for organ reconstruction offers a potential solution for replacement of tissue or whole 
organs. ASC does have one important advantage over the other sources of stem cells namely 
easy availability. There is no human tissue as expendable as adipose tissue, making it 
relatively easy to isolate adequate numbers of ASCs for possible human therapies. Human 
ASCs can be ideal cell source for tissue engineering. They are available in large quantities of 
cells per individual, multipotent, are transplantable in an autologous setting. 
However, further studies are needed before ASCs can be used clinically. In particular, 
investigators need to demonstrate the safety and efficacy of ASCs cells in animal models, 
either alone or in combination with novel biomaterial scaffolds.  
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